Liposomal cytotoxic compounds (TOT Biopharm)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLiposomal cytotoxic compounds (TOT Biopharm)
Drug Alias NameTOT-202TOT-201TLD-208TOT-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCells inhibitors
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTot Biopharm Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A